The short answer
Adults may meet the common FDA-labeled starting criteria with a BMI of 30 or higher, or a BMI of 27 or higher plus a weight-related condition. BMI alone does not guarantee eligibility or a prescription. A licensed provider must review the patient's complete medical profile before any treatment decision is made.
Completing an assessment does not guarantee eligibility or a prescription.
What BMI do you need to qualify for a GLP-1?
The FDA-labeled weight-management indications for currently approved GLP-1 receptor agonists such as semaglutide (Wegovy) and tirzepatide (Zepbound) describe two starting thresholds based on body mass index. According to the current Wegovy prescribing information and the current Zepbound prescribing information, these medications are indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults who meet one of the following criteria:
| BMI Range | FDA-Labeled Weight-Management Criteria | What This Means Clinically |
|---|---|---|
| Below 27 | Not within the labeled weight-management indication | A provider is unlikely to prescribe for weight management; other options may be discussed |
| 27–29.9 | Within labeled criteria only if at least one weight-related condition is present | Eligibility depends on documented comorbidities and full provider review |
| 30 or higher | Within labeled criteria for obesity | BMI threshold is met; full medical review is still required before any prescription |
Meeting a BMI threshold means you satisfy one part of the labeled indication. It does not mean a prescription is guaranteed. A licensed provider must still evaluate your complete health history, current medications, and any factors that could affect safety or appropriateness.
Can you qualify with a BMI between 27 and 30?
Yes — if you have at least one weight-related condition. The FDA-labeled indications for both Wegovy and Zepbound include adults with a BMI of 27 or higher who also have at least one weight-related comorbidity. Examples of conditions that may qualify include type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, and cardiovascular disease, among others.
The presence of a qualifying condition does not automatically result in a prescription. Your provider will assess whether the condition is documented, how it is currently managed, and whether GLP-1 therapy is appropriate given your full medical picture. Learn more about GLP-1 medications available online and what the review process involves.
Can you qualify without diabetes?
Yes. GLP-1 receptor agonists approved for chronic weight management — including Wegovy and Zepbound — are indicated for adults with obesity or overweight with a weight-related condition, regardless of whether diabetes is present. Diabetes is one possible qualifying comorbidity, not a requirement.
Some GLP-1 medications were originally approved for type 2 diabetes management and carry separate labeling for that indication. The weight-management indications are distinct. If you do not have diabetes, that does not disqualify you from being considered for GLP-1 weight-loss treatment, provided you meet the BMI criteria and your provider determines treatment is appropriate.
Why BMI does not determine eligibility by itself
BMI is a screening tool, not a clinical decision. Two people with identical BMI values can have very different health profiles, medication lists, and risk factors. A licensed provider reviewing your assessment will consider your BMI alongside:
- Your personal and family medical history
- Current prescription medications, over-the-counter drugs, and supplements
- Known allergies or prior reactions to medications
- Reproductive status and pregnancy plans
- Organ system history (pancreas, gallbladder, kidneys, thyroid, eyes)
- Prior use of GLP-1 medications and any reactions
- Surgical history and upcoming procedures
This is why the assessment you complete at DietsMD is designed to capture a thorough picture of your health — not just your height and weight. Read our GLP-1 weight loss guide for a broader overview of how these medications work and what to expect.
Which health-history factors affect eligibility?
Certain health-history factors are formal contraindications listed in the current prescribing labels for Wegovy and Zepbound. Others are conditions that a provider will carefully weigh when deciding whether treatment is appropriate. The table below summarizes key factors and how they are generally addressed — but this is not a substitute for a provider's individualized review.
| Health-History Factor | How It Is Generally Addressed |
|---|---|
| Personal or family history of medullary thyroid carcinoma (MTC) | Formal contraindication in current Wegovy and Zepbound labels; treatment is not appropriate |
| Multiple endocrine neoplasia syndrome type 2 (MEN 2) | Formal contraindication in current Wegovy and Zepbound labels; treatment is not appropriate |
| Prior serious hypersensitivity to semaglutide or tirzepatide | Formal contraindication in current labels; treatment is not appropriate |
| Pregnancy or active pregnancy plans | Weight-loss treatment should not be started during pregnancy; disclose to your provider |
| Severe gastroparesis or major digestive motility symptoms | Addressed as a population for which GLP-1 use is not recommended, not a universal contraindication; provider judgment required |
| History of pancreatitis | Not a universal contraindication; provider will assess history and severity individually |
| Gallbladder disease or prior cholecystectomy | Not a universal contraindication; provider will review history |
| Kidney disease or impaired renal function | Not a universal contraindication; provider will assess degree of impairment |
| Diabetic retinopathy | Not a universal contraindication; provider will consider history and current status |
| Upcoming surgery or procedure requiring deep sedation | Relevant to timing and dosing decisions; disclose to your provider and surgical team |
Disclosing your complete health history accurately is essential. Omitting information — even unintentionally — can affect the safety of any treatment decision.
Why current medications and supplements matter
GLP-1 medications can interact with other drugs and affect how your body absorbs oral medications. Your provider needs a complete list of everything you are currently taking, including:
- Prescription medications (including insulin and other diabetes drugs)
- Over-the-counter medications
- Vitamins, minerals, and herbal supplements
- Any current or prior GLP-1 medications
If you are already using a GLP-1 medication — whether prescribed or obtained elsewhere — disclose this during your assessment. Using two GLP-1 medications simultaneously is not appropriate and carries meaningful safety risks. Your provider will factor your current regimen into any treatment decision.
The FDA has also raised concerns about unapproved GLP-1 drugs used for weight loss. If you have questions about the difference between FDA-approved medications and compounded or unapproved alternatives, review the FDA's guidance on unapproved GLP-1 drugs. Compounded drugs are not FDA-approved, are not generics, and are not equivalent to or the same as an approved brand-name medication.
Do you need bloodwork before receiving GLP-1 treatment online?
Laboratory testing is individualized. There is no single universal lab panel required for every patient before a provider can review a GLP-1 request. Whether testing is needed — and which tests — depends on your health history, current medications, and the clinical judgment of the reviewing provider.
Some patients may be asked to provide recent lab results as part of their review. Others may not require testing before an initial decision is made. If your provider determines that labs are needed, they will communicate that to you as part of the review process. Do not assume that the absence of recent bloodwork automatically disqualifies you, or that having recent labs guarantees approval.
What happens during an online provider review?
When you complete your assessment at DietsMD, the information you submit is reviewed by a licensed provider. The provider evaluates your health history, BMI, medications, and any other relevant factors to determine whether GLP-1 treatment may be medically appropriate for you.
The provider may approve treatment, request additional information or documentation, recommend a different approach, or determine that treatment is not appropriate based on your profile. You will be notified of the outcome. Learn more about how the online visit works at DietsMD.
A provider review is a clinical decision — not an automated approval. The reviewing provider exercises independent medical judgment based on the information you provide.
How to prepare for the assessment
To help your provider make an informed decision, gather the following before you begin:
- Your current height and weight (to calculate BMI)
- A list of all current medications, including doses
- A list of supplements, vitamins, and herbal products
- Known allergies or prior medication reactions
- Relevant medical history, including any diagnoses listed in the health-history table above
- Family history of medullary thyroid carcinoma or MEN 2
- Recent lab results, if available and relevant
- Information about any upcoming surgeries or procedures
- Your pregnancy status and plans, if applicable
Providing complete and accurate information gives your provider the best foundation for a safe and appropriate review. Incomplete or inaccurate information can affect the outcome and your safety.
What happens if your BMI is below 27?
If your BMI is below 27, you fall outside the FDA-labeled weight-management indications for currently approved GLP-1 medications. A provider is unlikely to prescribe these medications for weight management at that BMI range.
This does not mean there are no options available to you. A provider may discuss other approaches to weight management that are appropriate for your situation. If you are unsure whether your BMI meets the threshold, completing an assessment allows a licensed provider to review your specific profile and provide guidance.
For context on what results and timelines look like for patients who do qualify, see our overview of GLP-1 weight loss results and timelines.
Frequently asked questions
Does a BMI of 30 automatically qualify me?
No. A BMI of 30 or higher meets one part of the FDA-labeled weight-management criteria, but it does not guarantee eligibility or a prescription. A licensed provider must review your complete health history, medications, and any contraindications before making a treatment decision.
Can I qualify with a BMI of 27?
Possibly. The FDA-labeled indications include adults with a BMI of 27 or higher who also have at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea. Your provider will assess whether your condition qualifies and whether treatment is appropriate overall.
Can I get a GLP-1 entirely online?
DietsMD offers an online assessment and provider review process. If a licensed provider determines that treatment is medically appropriate, a prescription may be issued and medication delivered to your home. Learn more about how the online visit works. Completing an assessment does not guarantee a prescription.
Do I need diabetes?
No. The weight-management indications for Wegovy and Zepbound do not require a diabetes diagnosis. Diabetes is one possible qualifying comorbidity for patients with a BMI between 27 and 29.9, but it is not required for patients with a BMI of 30 or higher.
Will I need bloodwork?
Laboratory testing is individualized. Some patients may be asked to provide recent lab results; others may not. Your provider will communicate whether testing is needed as part of your review. There is no single universal required lab panel.
Does prior pancreatitis automatically disqualify me?
No. Prior pancreatitis is not a universal contraindication in the current Wegovy or Zepbound prescribing labels. However, your provider will review your history and severity individually. Disclose any history of pancreatitis accurately during your assessment.
Can I use two GLP-1 medications together?
No. Using two GLP-1 medications simultaneously is not appropriate and carries meaningful safety risks. If you are currently using any GLP-1 medication, disclose this during your assessment. Your provider will factor your current regimen into any treatment decision.
What happens if I do not qualify?
If a provider determines that GLP-1 treatment is not appropriate for you, you will be notified. The provider may suggest alternative approaches or recommend that you follow up with your primary care provider. Completing an assessment does not guarantee any specific outcome.
Ready to Find Out Whether Treatment May Be Appropriate?
Complete your health information for review by a licensed provider. Treatment is prescribed only when the reviewing provider determines that it is medically appropriate.
Completing an assessment does not guarantee eligibility or a prescription.
Medical Disclaimer
The information in this article is intended for general educational purposes only and does not constitute medical advice, a diagnosis, or a treatment recommendation. It is not a substitute for the professional judgment of a licensed healthcare provider. Individual eligibility for GLP-1 medications depends on a complete medical evaluation by a qualified provider. FDA-labeled indications describe general criteria; they do not guarantee that any specific individual will receive or benefit from treatment. Always disclose your complete health history, medications, supplements, allergies, and pregnancy status to your provider. If you have questions about your health or a specific medical condition, consult a licensed healthcare professional.
